Congenital adrenal hyperplasia

Search Trials
Androgen Reduction in Congenital Adrenal Hyperplasia
Status:
Not yet recruiting
Last Changed:
Sep 9, 2019
First Changed:
Jun 7, 2018
Disease(s):
Congenital Adrenal Hyperplasia
Intervention(s):
Abiraterone acetatePlaceboHydrocortisoneFludrocortisone
Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia
Status:
Recruiting
Last Changed:
Jun 18, 2018
First Changed:
Jun 8, 2018
Disease(s):
Congenital Adrenal Hyperplasia (CAH)
Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1
Status:
Recruiting
Last Changed:
Jan 25, 2019
First Changed:
Oct 14, 2015
Disease(s):
Congenital Adrenal Hyperplasia
Intervention(s):
Abiraterone acetate
Study of UK Adults With Congenital Adrenal Hyperplasia.
Status:
Completed
Last Changed:
Jun 11, 2012
First Changed:
Sep 9, 2008
Disease(s):
Congenital Adrenal Hyperplasia
Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia
Status:
Completed
Last Changed:
Jun 26, 2019
First Changed:
Aug 22, 2017
Disease(s):
Congenital Adrenal Hyperplasia
Intervention(s):
SPR001

Connect. Empower. Inspire.